Login
From:
Pulmonary Fibrosis News
(Uncensored)
subscribe
Oral therapy GRI-0621 has encouraging safety results for IPF in interim analysis
https://pulmonaryfibrosisnews.com/news/oral-therapy-gri-0621-encouraging-safety-results-ipf-interim-analysis/
links
backlinks
Tagged with:
news
clinical trial
idiopathic pulmonary fibrosis
GRI-0621, an experimental oral therapy for IPF, has so far been tolerated well in an ongoing Phase 2 clinical trial.
Roast topics
Find topics
Find it!
